期刊文献+

去甲基化干预胃癌SGC7901细胞前后食管癌相关基因4基因的表达变化

ECRG4 gene expression in gastric cancer cells SGC7901 before and after methylation intervention
在线阅读 下载PDF
导出
摘要 目的:研究SGC7901细胞与GES-1细胞中食管癌相关基因4(ECRG4)蛋白表达差异及5-杂氮-2′-脱氧胞苷(5-Aza-CdR)干预前后SGC7901细胞中ECRG4基因表达变化情况。方法:Westernblot检测SGC7901细胞、GES-1细胞中ECRG4编码蛋白的表达,以不同浓度(0、5、10μmol/L)5-Aza-CdR干预SGC7901,48h后再以Westernblot检测ECRG4编码蛋白的表达情况。结果:SGC7901细胞中ECRG4蛋白表达较低而GES-1细胞中表达较高,差异有统计学意义(P<0.001)。以5-Aza-CdR干预SGC7901细胞48h,随着药物浓度增加,ECRG4蛋白表达逐渐上调,10μmol/L处理组比5μmol/L组更明显,差异有统计学意义(P<0.01)。结论:SGC7901细胞中ECRG4蛋白的表达量明显低于GES-1细胞;以5-Aza-CdR处理SGC7901细胞48h后ECRG4蛋白表达有上调,且10μmol/L组比5μmol/L组其恢复表达作用更明显。 Objective To study the difference of ECRG4 protein expression between SGC7901 cells and GES-1 cells and the changes of ECRG4 gene expression in SGC7901 before and after 5-Aza-CdR intervention. Methods Western blot was used to detect ECRG4 protein expression in SGC7901 and GES-I. SGC7901 cells were then intervented by 5-Aza-CdR at different concentrations (0, 5, and 10 μmol/L). 48 h after intervention, Western blot was used again to determine ECRG4 protein expression. Results ECRG4 protein expressions were lower in SGC7901 and higher in GES-I, with a statistical significant difference (P 〈 0.001). 48 h after intervetion with 5-Aza-CdR for SGC7901, with an increase in drug concentration, ECRG4 protein expression upregulated gradually; the change was more obvious in the 10μmol/L group than in the 5 μmol/L group, with a statistical difference (P 〈 0.01 ). Conclusions The quantity of ECRG4 protein expression is smaller in SGC7901 cells than in GES-1 cells. 48 h after treatment with 5-Aza-CdR, ECRG4 protein expression is upregulated in SGC7901, and the upregulation is more significant in the 10 μmol/L group than in the 5 μmol/L group.
出处 《实用医学杂志》 CAS 北大核心 2013年第3期346-348,共3页 The Journal of Practical Medicine
基金 湖南省教育厅项目(编号:10C0956) 湖南省自然科学基金项目(编号:11JJ5068)
关键词 胃肿瘤 SGC7901 食管癌相关基因4 5-杂氮-2’-脱氧胞苷 Stomach neoplasms SGC7901 ECRG4 5-aza-2'-deoxycytidine
  • 相关文献

参考文献9

  • 1Chen W Q,Zhang S W,Zou X N. Cancer Incidence And Mortality in China,2006[J].Chinese Journal of Cancer Research,2011,(01):3-9.doi:10.1007/s11670-011-0003-9.
  • 2党冬梅,魏小萍,惠起源.胃癌分子机制的研究进展[J].现代肿瘤医学,2005,13(3):427-429. 被引量:1
  • 3Steck E,Breit S,Breusch S J. Enhanced expression of the human chitinase 3-like 2 gene(Ykl-39) but not chitinase 3-Like 1 gene(Ykl-40) in osteoarthritic cartilage[J].Biochemical and Biophysical Research Communications,2002,(01):109-115.doi:10.1016/S0006-291X(02)02585-8.
  • 4Li L W,Yu X Y,Yang Y. Expression of esophageal cancer related gene 4 (ECRG4),a novel tumor suppressor gene,in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo[J].International Journal of Cancer,2009,(07):1505-1513.
  • 5G(o)tze S,Feldhaus V,Traska T. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma[J].BMC Cancer,2009.447.
  • 6方圆,马党,危文素,徐镭,付泊,刘展.ECRG4基因在人胃腺癌组织中的表达及意义[J].晓庄学院学报(医学版),2012,9(1):69-73. 被引量:4
  • 7Kang G H,Lee S,Kim J S. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis[J].Laboratory Investigation,2003,(05):635-641.
  • 8黄毕林,胡世莲,沈干,沈国栋,孙玉蓓,徐维平,黄大兵,王海,方中良.地西他滨联合化疗药物对胃癌SGC-7901细胞增殖的抑制作用[J].实用医学杂志,2012,28(1):39-41. 被引量:2
  • 9Taberlay P C,Jones P A. DNA methylation and cancer[J].Progress in Drug Research,2011,(01):1-23.

二级参考文献29

  • 1An Gao Xu Shao Guang Li Ji Hong Liu Ai Hua Gan Research Laboratory of Digestive Disease,Huizhou Central People’s Hospital,Huizhou 516001,Guangdong Province,ChinaDr.An Gao Xu graduated from Guangdong Medical College in 1984.He is an associate physician-in-chief,specializing in the research and treatment of gastrointestinal and liver tumors.He has published 24 papers and 1 book..Function of apoptosis and expression of the proteins Bcl-2,p53 and C-myc in the development of gastric cancer[J].World Journal of Gastroenterology,2001,7(3):403-406. 被引量:92
  • 2王贺玲,王学清,李岩,孙军.5-Aza-CdR对胃癌细胞系生长及Apaf-1基因异常甲基化的影响[J].世界华人消化杂志,2007,15(3):221-227. 被引量:7
  • 3田相龙,钟捷,李彪,黄玮,张一帆,王俊,顾燕云.5-杂氮-2’-脱氧胞苷对人胃癌裸鼠移植瘤的抑瘤作用[J].上海交通大学学报(医学版),2007,27(5):533-536. 被引量:6
  • 4Parikin D, Bray F, Ferlay J, et al. Global cancer statistics 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 5Leung W, Wu M, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice [J]. Lancet Oncol, 2008, 9(3): 279-287.
  • 6Watanabe Y, Ueda H, Etoh T, et al. A change in promotermethylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer ~Jl- Anticancer Res, 2007, 27(3B):1449-1452.
  • 7Kurkjian C, Kummar S, Murgo A. DNA methylation: its role in cancer development and therapy [J]. Curr Probl Cancer, 2008, 32(5) : 187-235.
  • 8Monparler R L. Epigenetic therapy of cancer with 5-Aza-2'- denxycytidine (decitabine) [J]. Semin Oncol, 2005, 32(5): 443-451.
  • 9Zhang Y, Qu X, Jing W, et al. GSTP1 determines cis- platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling [J]. Anti-Cancer Drugs, 2009, 20(3): 208- 214.
  • 10Reinhold W C, Reimers M A, Lorenzi P, et al. Multifactorial regulation of E-cadherin expression: an integrative study [J]. Mol Cancer Ther, 2010, 9(1): 1-16.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部